On April 28, 2021 MorphoSys AG (FSE: MOR; Prime Standard Segment, MDAX & TecDAX; NASDAQ: MOR), a commercial-stage biopharmaceutical company and a leader in antibody, protein and peptide technologies, reported that it will publish its results for the first quarter of 2021 on May 5, 2021 at 10:00pm CEST (4:00pm EDT) (Press release, MorphoSys, APR 28, 2021, View Source [SID1234578629]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

MorphoSys’ Management Board will host a conference call and webcast on May 6, 2021 at 2:00pm CEST (8:00am EDT) to present the first quarter and first 3-month financial results 2021 and provide an outlook for 2021.

The conference call will start with a presentation by the Management Board followed by a Q&A session. Following Board Members will be on the call: